Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$2.5 million.

  • Orthopediatrics' Non Operating Income rose 3083.17% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 14494.42%. This contributed to the annual value of -$6.9 million for FY2024, which is 22721.09% down from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Non Operating Income is -$2.5 million, which was up 3083.17% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Non Operating Income registered a high of $21.4 million during Q3 2022, and its lowest value of -$4.7 million during Q1 2021.
  • Moreover, its 5-year median value for Non Operating Income was $787000.0 (2023), whereas its average is $1.3 million.
  • In the last 5 years, Orthopediatrics' Non Operating Income crashed by 95312.5% in 2021 and then soared by 174909.09% in 2022.
  • Quarter analysis of 5 years shows Orthopediatrics' Non Operating Income stood at $5.8 million in 2021, then tumbled by 92.93% to $413000.0 in 2022, then skyrocketed by 181.6% to $1.2 million in 2023, then plummeted by 302.41% to -$2.4 million in 2024, then fell by 4.93% to -$2.5 million in 2025.
  • Its last three reported values are -$2.5 million in Q3 2025, $4.7 million for Q2 2025, and $1.6 million during Q1 2025.